Seeking Alpha

Endo Pharmaceuticals (ENDP): Q4 EPS of $1.40 beats by $0.08. Revenue of $803.4M (+57.2% Y/Y)...

Endo Pharmaceuticals (ENDP): Q4 EPS of $1.40 beats by $0.08. Revenue of $803.4M (+57.2% Y/Y) in-line. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)